View in EDS

Major partial response to crizotinib, a dual MET/ALK inhibitor, in a squamous cell lung (SCC) carcinoma patient with de novo c-MET amplification in the absence of ALK rearrangement.

Saved in:
Bibliographic Details
Title: Major partial response to crizotinib, a dual MET/ALK inhibitor, in a squamous cell lung (SCC) carcinoma patient with de novo c-MET amplification in the absence of ALK rearrangement.
Authors: Schwab R; KPS Medical Biotechnology and Healthcare Services Ltd., Budapest, Hungary., Petak I; KPS Medical Biotechnology and Healthcare Services Ltd., Budapest, Hungary; Hungarian Academy of Sciences, Pathobiochemistry Research Group, Budapest, Hungary. Electronic address: petak@kps.hu., Kollar M; KPS Medical Biotechnology and Healthcare Services Ltd., Budapest, Hungary., Pinter F; KPS Medical Biotechnology and Healthcare Services Ltd., Budapest, Hungary., Varkondi E; KPS Medical Biotechnology and Healthcare Services Ltd., Budapest, Hungary., Kohanka A; KPS Medical Biotechnology and Healthcare Services Ltd., Budapest, Hungary., Barti-Juhasz H; KPS Medical Biotechnology and Healthcare Services Ltd., Budapest, Hungary., Schönleber J; Semmelweis University, Ist Department of Gynecology, Budapest, Hungary., Brauswetter D; Hungarian Academy of Sciences, Pathobiochemistry Research Group, Budapest, Hungary., Kopper L; Semmelweis University, Ist Institute of Pathology and Experimental Cancer Research, Budapest, Hungary., Urban L; Matrahaza Healthcare Center and University Teaching Hospital, Matrahaza, Hungary.
Source: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2014 Jan; Vol. 83 (1), pp. 109-11. Date of Electronic Publication: 2013 Oct 19.
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 24192513
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Major partial response to crizotinib, a dual MET/ALK inhibitor, in a squamous cell lung (SCC) carcinoma patient with de novo c-MET amplification in the absence of ALK rearrangement.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Schwab+R%22">Schwab R</searchLink>; KPS Medical Biotechnology and Healthcare Services Ltd., Budapest, Hungary.<br /><searchLink fieldCode="AU" term="%22Petak+I%22">Petak I</searchLink>; KPS Medical Biotechnology and Healthcare Services Ltd., Budapest, Hungary; Hungarian Academy of Sciences, Pathobiochemistry Research Group, Budapest, Hungary. Electronic address: petak@kps.hu.<br /><searchLink fieldCode="AU" term="%22Kollar+M%22">Kollar M</searchLink>; KPS Medical Biotechnology and Healthcare Services Ltd., Budapest, Hungary.<br /><searchLink fieldCode="AU" term="%22Pinter+F%22">Pinter F</searchLink>; KPS Medical Biotechnology and Healthcare Services Ltd., Budapest, Hungary.<br /><searchLink fieldCode="AU" term="%22Varkondi+E%22">Varkondi E</searchLink>; KPS Medical Biotechnology and Healthcare Services Ltd., Budapest, Hungary.<br /><searchLink fieldCode="AU" term="%22Kohanka+A%22">Kohanka A</searchLink>; KPS Medical Biotechnology and Healthcare Services Ltd., Budapest, Hungary.<br /><searchLink fieldCode="AU" term="%22Barti-Juhasz+H%22">Barti-Juhasz H</searchLink>; KPS Medical Biotechnology and Healthcare Services Ltd., Budapest, Hungary.<br /><searchLink fieldCode="AU" term="%22Schönleber+J%22">Schönleber J</searchLink>; Semmelweis University, Ist Department of Gynecology, Budapest, Hungary.<br /><searchLink fieldCode="AU" term="%22Brauswetter+D%22">Brauswetter D</searchLink>; Hungarian Academy of Sciences, Pathobiochemistry Research Group, Budapest, Hungary.<br /><searchLink fieldCode="AU" term="%22Kopper+L%22">Kopper L</searchLink>; Semmelweis University, Ist Institute of Pathology and Experimental Cancer Research, Budapest, Hungary.<br /><searchLink fieldCode="AU" term="%22Urban+L%22">Urban L</searchLink>; Matrahaza Healthcare Center and University Teaching Hospital, Matrahaza, Hungary.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228800805%22">Lung cancer (Amsterdam, Netherlands)</searchLink> [Lung Cancer] 2014 Jan; Vol. 83 (1), pp. 109-11. <i>Date of Electronic Publication: </i>2013 Oct 19.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Scientific+Publishers%22">Elsevier Scientific Publishers </searchLink><i>Country of Publication: </i>Ireland <i>NLM ID: </i>8800805 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1872-8332 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201695002%22">01695002 </searchLink><i>NLM ISO Abbreviation: </i>Lung Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=24192513
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.lungcan.2013.10.006
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 109
    Titles:
      – TitleFull: Major partial response to crizotinib, a dual MET/ALK inhibitor, in a squamous cell lung (SCC) carcinoma patient with de novo c-MET amplification in the absence of ALK rearrangement.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Schwab R
      – PersonEntity:
          Name:
            NameFull: Petak I
      – PersonEntity:
          Name:
            NameFull: Kollar M
      – PersonEntity:
          Name:
            NameFull: Pinter F
      – PersonEntity:
          Name:
            NameFull: Varkondi E
      – PersonEntity:
          Name:
            NameFull: Kohanka A
      – PersonEntity:
          Name:
            NameFull: Barti-Juhasz H
      – PersonEntity:
          Name:
            NameFull: Schönleber J
      – PersonEntity:
          Name:
            NameFull: Brauswetter D
      – PersonEntity:
          Name:
            NameFull: Kopper L
      – PersonEntity:
          Name:
            NameFull: Urban L
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2014 Jan
              Type: published
              Y: 2014
          Identifiers:
            – Type: issn-electronic
              Value: 1872-8332
          Numbering:
            – Type: volume
              Value: 83
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Lung cancer (Amsterdam, Netherlands)
              Type: main
ResultId 1